NICE green-light for Novartis skin drug
May 29, 2015Sales and Marketing Cosentyx, IL-17, NICE, Novartis, Secukinumab
NICE has released positive draft guidance for three treatments, including the first in a new generation of psoriasis drugs. Novartis’ …
Lilly and AstraZeneca collaborate on cancer trials
May 29, 2015Research and Development AstraZeneca, Cancer, Eli Lilly, MedImmune, immuno-oncology, immunotherapy, lilly, oncology, phase I
AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …
Pfizer gets first approval for rare lung disease
May 29, 2015Sales and Marketing FDA, Pfizer, Rapamune, lung disease
Pfizer’s Rapamune will become the first drug available to treat the very rare lung disease lymphangioleiomyomatosis (LAM) after receiving approval …
Teva settles generic ‘pay-to-delay’ case for $1.2 billion
May 29, 2015Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil
Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …
Sanofi plays host to German chancellor Angela Merkel
May 29, 2015Manufacturing and Production, Medical Communications, Sales and Marketing France, Germany, Sanofi, angela, brett wells, merkel
German Chancellor Dr Angela Merkel met with Sanofi bosses in Frankfurt to discuss antibiotics and open a new manufacturing facility. …
Huntingdon and Harlan names corporate marketing VP
May 29, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntingdon and Harlan, joseph bedford
UK’s Huntingdon Life Sciences and Harlan Laboratories has appointed Dr Joseph Bedford to serve as corporate vice president of global …
Two new diabetes drugs approved
May 28, 2015Sales and Marketing Japan, Takeda, diabetes in China, lilly
Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …
Eisai seeks new ALS drug approval
May 28, 2015Sales and Marketing Eisai, Japan, als, mecobalamin
Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …
Actavis and Valeant see FDA approval for IBS drugs
May 28, 2015Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells
Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …
NICE sets out office for market access plans
May 28, 2015Sales and Marketing ABPI, EMA, NHS, NICE, eams, market access
The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …
Kayentis names four committee members
May 28, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Patrizia Paterlini-Brechot, Pierre-Olivier Goineau, Ronan Roussel, Stephen Senn, kayentis
French software solutions provider for clinical trials Kayentis has formed a strategic committee comprising four industry veterans. Accepting director Guillaume …
Another Chinese health official arrested for corruption
May 27, 2015Medical Communications, Sales and Marketing China, GSK, bribery, huang fenping, wang yu
A Chinese health official has been arrested on accusations of bribery as the country continues to crack down on corruption …
Novartis reveals ASCO plans
May 27, 2015Sales and Marketing ASCO, GSK, Novartis
Novartis’ first ASCO conference since buying GlaxoSmithKline’s oncology business will be showcasing drugs from the acquisition. The two firms swapped …
Amgen cold sore virus drug shows ‘significant’ cancer benefit
May 27, 2015Research and Development, Sales and Marketing Amgen, Cancer, cold sore, t-vec
Amgen is pinning its hopes on investigational viral treatment T-VEC following promising results from a ‘landmark’ skin cancer study. People …
Eisai epilepsy drug sees EMA nod
May 27, 2015Research and Development, Sales and Marketing Eisai, Fycompa, ema. epilepsy
Eisai’s UK subsidiary has received a positive opinion from the European Medicines Agency for using Fycompa for the adjunctive treatment …
Sanofi appoints external affairs VP
May 27, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, suresh kumar
Sanofi has said Suresh Kumar is to join the French pharma giant on its executive committee and become executive vice …
PrimeVigilance and Sound Opinion join forces
May 26, 2015acquisition, medical information, primevigilance
Ergomed plc, the parent company of PrimeVigilance, has acquired Sound Opinion, one of the UK’s leading Medical Information (MI) service …
Sanofi prostate cancer drug to remain on CDF
May 26, 2015Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate
Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …
Otsuka, ViiV and AstraZeneca named in ABPI code complaints
May 26, 2015Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Otsuka, PMCPA, ViiV
A ‘senior male employee’ of Otsuka Pharmaceuticals “potentially brought the industry into disrepute” by plying a female healthcare professional with …
Amgen pulls out of psoriasis deal with AstraZeneca
May 26, 2015Sales and Marketing Amgen, AstraZeneca, psoriasis
Amgen has ended its agreement with AstraZeneca to develop a new biologic for psoriasis, because of the likelihood of ‘restrictive …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
